[
    "{\"step_by_step_thinking\": \"Erenumab is a medication that belongs to a class of drugs called calcitonin gene-related peptide (CGRP) inhibitors. Trigeminal neuralgia is a condition characterized by severe facial pain. To determine if erenumab is effective for trigeminal neuralgia, we need to consider the available evidence. It is important to note that erenumab is primarily used for the prevention of migraine headaches and not specifically approved for the treatment of trigeminal neuralgia. However, there is some evidence suggesting that CGRP inhibitors, including erenumab, may have a role in the management of trigeminal neuralgia. Therefore, the answer to the question is:\", \"answer_choice\": \"A. yes\"}"
]